350 related articles for article (PubMed ID: 27843953)
1. Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes.
Nunemaker CS
J Diabetes Res; 2016; 2016():2846570. PubMed ID: 27843953
[TBL] [Abstract][Full Text] [Related]
2. Macrophages and islet inflammation in type 2 diabetes.
Eguchi K; Manabe I
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization.
Cucak H; Grunnet LG; Rosendahl A
J Leukoc Biol; 2014 Jan; 95(1):149-60. PubMed ID: 24009176
[TBL] [Abstract][Full Text] [Related]
4. Setting the Stage for Islet Autoimmunity in Type 2 Diabetes: Obesity-Associated Chronic Systemic Inflammation and Endoplasmic Reticulum (ER) Stress.
Brooks-Worrell BM; Palmer JP
Diabetes Care; 2019 Dec; 42(12):2338-2346. PubMed ID: 31748213
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity.
Donath MY; Dalmas É; Sauter NS; Böni-Schnetzler M
Cell Metab; 2013 Jun; 17(6):860-872. PubMed ID: 23747245
[TBL] [Abstract][Full Text] [Related]
6. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
7. Islet inflammation in type 2 diabetes and physiology.
Eguchi K; Nagai R
J Clin Invest; 2017 Jan; 127(1):14-23. PubMed ID: 28045399
[TBL] [Abstract][Full Text] [Related]
8. Macrophages, immunity, and metabolic disease.
McNelis JC; Olefsky JM
Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
[TBL] [Abstract][Full Text] [Related]
9. Islet inflammation: a unifying target for diabetes treatment?
Imai Y; Dobrian AD; Morris MA; Nadler JL
Trends Endocrinol Metab; 2013 Jul; 24(7):351-60. PubMed ID: 23484621
[TBL] [Abstract][Full Text] [Related]
10. Monocytes play different roles in stimulating T cells in obese diabetic individuals.
Dai X; Zhan J; Demmy TA; Poordad FB; Fauceglia PL; Zhang H; Wu L
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):374-83. PubMed ID: 26246197
[TBL] [Abstract][Full Text] [Related]
11. An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.
Sharma PR; Mackey AJ; Dejene EA; Ramadan JW; Langefeld CD; Palmer ND; Taylor KD; Wagenknecht LE; Watanabe RM; Rich SS; Nunemaker CS
Endocrinology; 2015 Sep; 156(9):3147-56. PubMed ID: 26018251
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.
Westwell-Roper C; Nackiewicz D; Dan M; Ehses JA
Immunol Cell Biol; 2014 Apr; 92(4):314-23. PubMed ID: 24492799
[TBL] [Abstract][Full Text] [Related]
13. Connecting type 1 and type 2 diabetes through innate immunity.
Odegaard JI; Chawla A
Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007724. PubMed ID: 22393536
[TBL] [Abstract][Full Text] [Related]
14. Regulation of metabolism by the innate immune system.
Lackey DE; Olefsky JM
Nat Rev Endocrinol; 2016 Jan; 12(1):15-28. PubMed ID: 26553134
[TBL] [Abstract][Full Text] [Related]
15. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile.
DeFuria J; Belkina AC; Jagannathan-Bogdan M; Snyder-Cappione J; Carr JD; Nersesova YR; Markham D; Strissel KJ; Watkins AA; Zhu M; Allen J; Bouchard J; Toraldo G; Jasuja R; Obin MS; McDonnell ME; Apovian C; Denis GV; Nikolajczyk BS
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5133-8. PubMed ID: 23479618
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue inflammation in the pathogenesis of type 2 diabetes.
Kohlgruber A; Lynch L
Curr Diab Rep; 2015 Nov; 15(11):92. PubMed ID: 26374569
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet inflammation: an emerging role for chemokines.
Collier JJ; Sparer TE; Karlstad MD; Burke SJ
J Mol Endocrinol; 2017 Jul; 59(1):R33-R46. PubMed ID: 28420714
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
Rabinovitch A; Suarez-Pinzon WL
Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467
[TBL] [Abstract][Full Text] [Related]
20. An immune origin of type 2 diabetes?
Kolb H; Mandrup-Poulsen T
Diabetologia; 2005 Jun; 48(6):1038-50. PubMed ID: 15864529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
